Hypersensitivity to any of the components of the drug, oppression of bone marrow hematopoiesis, acute intermittent porphyria, deficiency of glucose-6-phosphate dehydrogenase, liver failure, renal failure, skin diseases (fungal diseases, psoriasis, eczema), pregnancy, breastfeeding period, neonatal period up to 4 weeks).